Recent developments in the identification and biosynthesis of antitumor drugs derived from microorganisms
{{output}}
Secondary metabolites in microorganisms represent a resource for drug discovery and development. In particular, microbial-derived antitumor agents are in clinical use worldwide. Herein, we provide an overview of the development of classical antitumor drugs der... ...
